Aztreonam Data to Be Presented at European Cystic Fibrosis Society Conference
Seattle (ots/PRNewswire) - - Data on Microbiology of an Investigational Inhaled Antibiotic for Cystic Fibrosis to Be Presented in Crete Dr. Jane L. Burns will present Corus Pharma's Aztreonam Lysinate for Inhalation (AI) clinical Phase 2 microbiology results at the European Cystic Fibrosis Society Conference (ECFS) in Crete on Friday, June 24, 2005 at ...
mehr